Clinical Trial Update: Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effect of finerenone on myocardial remodeling in patients with diabetic kidney disease and heart failure, including hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Heart Failure with Mildly Reduced Ejection Fraction
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: Cathay General Hospital | Conditions: Heart Failure and Preserved Ejection Fraction, Heart Failure | Phase 4 | Status: ENROLLING_BY_INVITATION